INVESTOR NEWS

Mar 28, 2019

Gentian Diagnostics appoints Torsten Knüttel as VP Reseach & Development

Moss, 28.03.19

Mar 20, 2019

Results from Calprotectin study - March 2019

Moss 20.03.18

Mar 01, 2019

4Q 2018 Results and preliminary annual report

Moss, 28 February 2019

Dec 19, 2018

Financial calendar 2018

Financial calendar for Gentian Diagnostics AS

Nov 30, 2018

Third Quarter Financial Report - 2018

Moss, 16.11.2018

Oct 03, 2018

Gentian Diagnostics AS - Primary insider notification

(Oslo, Norway, October 03, 2018) Vatne Equity AS has acquired 135,526 shares in Gentian Diagnostics AS at an..

Oct 01, 2018

Results from Calprotectin study

Moss 01.10.18

Sep 24, 2018

Patent licensing agreement

Moss 24.09.2018 Gentian Diagnostics AS announces today that one of its subsidiaries has entered into an..

Aug 17, 2018

Meldepliktig handel - Gentian Diagnostics AS

Holta Life Sciences AS, et selskap 100 % eid av Holta Invest AS, har 17.08.2018 solgt 13 800 aksjer i Gentian..

Aug 17, 2018

2nd Quarter and First Half 2018 Report

Moss, 17 August 2018